Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CYTOO
Grenoble, France
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
CYTOO provides an advanced in vitro human muscle model (MyoScreen) to model muscle pathologies, enabling phenotypic screening and drug candidate evaluation in vitro for both rare neuromuscular diseases and chronic metabolic/muscle disorders. The company does not have clinical-stage results but offers preclinical proprietary and partnered discovery and validation programs.[2][1][4][5]
- Therapeutic areas
- CardiovascularEndocrinologyNeurologyMetabolic DisordersOther
- Modalities
- Cell therapySmall moleculeBiologic
- Industry
- Drug Discovery Services
02
Partnerships
Multiple undisclosed pharmaceutical and biotechnology companies specializing in muscle health and drug discovery[4][2]
Beyond the preview
Go deeper on CYTOO.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CYTOO.